Pelo Biotech
PELOBiotech GmbH, a German biotech founded in 2012, develops and distributes specialized cell culture media, primary cells, and tools for research and clinical applications. It serves pharmaceutical, biotech, and academic institutions globally through direct sales and a curated network of 20+ third-party suppliers.
- Company typePrivate
- Founded2012
- HeadquartersMartinsried, Germany
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Pelo Biotech does
PELOBiotech GmbH is a German biotech company headquartered in Planegg (Martinsried), Germany, founded in 2012 and operating with 1-10 employees. The company develops and distributes specialized cell culture solutions for human primary cells and adjacent research workflows, spanning primary cells, stem cells, iPS cells, customized cell culture media, tissue dissociation enzymes, 3D cell culture tools, assays, proteins, antibodies, exosome tools, and tissue samples. Its proprietary Cellovations® brand represents in-house developed media products, while the firm simultaneously functions as a European distributor aggregating 20+ third-party suppliers (VitaCyte, TissueClick, QRET Technologies, THT Biomaterials, Akron Biotech, BioLife Solutions, REPROCELL, Cyagen, Cell Applications, Cell Biologics, and others).
The portfolio addresses drug discovery, regenerative medicine, toxicology testing, and clinical cell therapy applications, with technical emphasis on animal component-free (ACF) formulations for reproducible science and GMP-quality manufacturing for clinical/industrial translation. The 3D cell culture technologies and synthetic ECM partnerships (TissueClick, THT Biomaterials) position the company in organoid and advanced cancer model workflows, while GMP-grade enzymes (e.g., rCollagenase HI GMP & AOF from VitaCyte) target regulated cell therapy manufacturers.
PELOBiotech operates a direct-to-consumer and inside-sales model with no published pricing — all quotes are issued on inquiry via website forms, phone (+49 89 517 286 59-0), or email ([email protected]). Marketing runs through content (website, downloads, references), organic social (LinkedIn, Twitter, Instagram), webinars, and newsletters, with global reach via regional distributor/reseller channels. No disclosed funding rounds, M&A activity, named end customers, leadership additions, or revenue figures were identified in available sources, and the sole named individual is Dr. Peter Frost, associated with the Cellovations® brand.
Pelo Biotech firmographics
Firmographics- Name
- Pelo Biotech
- Legal name
- PELOBiotech GmbH
- Website
- https://pelobiotech.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- PELOBiotech GmbH, a German biotech founded in 2012, develops and distributes specialized cell culture media, primary cells, and tools for research and clinical applications. It serves pharmaceutical, biotech, and academic institutions globally through direct sales and a curated network of 20+ third-party suppliers.
- Ownership category
- akta.pro rank
Pelo Biotech industry classification
Industry- Product category
- Cell Culture Products and Life Science Reagents
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers) (HLAGAIAG)
- akta.pro secondary industry
- Bioprocess Consumables & Reagents (resins, membranes, media components, buffers) (HLAAAJAI)
Keywords
Where Pelo Biotech is headquartered
LocationHeadquarters
- HQ city
- Martinsried
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
Pelo Biotech business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- Cell and Biological Products Sales: Sale of primary cells, stem cells, iPS cells, cell culture media, tissue dissociation enzymes, assays, proteins, antibodies, and exosome tools. Products are sold individually with catalog numbers, with pricing handled via inquiry/quote system.
- Supplier/Distribution Revenue: PELOBiotech acts as a distributor for third-party suppliers (VitaCyte, TissueClick, QRET Technologies, THT Biomaterials, and others), earning revenue through markup on products sourced from these partners.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Quote-based pricing for all products |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels6 records
Pelo Biotech product offering
Product offeringCore offering
PELOBiotech GmbH develops, manufactures, and supplies specialty cell culture products for human primary cells, including a proprietary Cellovations® range of cell culture media (with Animal Component-Free and GMP-grade options), primary human and animal cells, stem cells, tissue dissociation enzymes, 3D cell culture systems, assays, proteins, and antibodies. The company serves as a one-stop shop for the cells–media–tools workflow and additionally distributes selected third-party life-science brands.
Product overview
PELOBiotech is a cell culture solutions provider offering one of the world's largest portfolios of human and animal cells, cell culture media, and cell culture tools. The company operates as both a product developer and distributor, with its proprietary Cellovations® brand representing its in-house developed products. The portfolio includes core product categories: Cells (primary cells, stem cells, iPS cells), Cell culture media (specialized formulations for various cell types), Cell culture tools (ECMs, coating solutions, 3D technologies, hydrogels), Assays (chimerism, angiogenesis, ELISA kits), Proteins & small molecules (including GMP proteins), Antibodies, Sample preparation products (Resyn®, Bio-Nobile), Tissue dissociation enzymes (collagenases, proteases), Tissues & Tissue RNA, and Exosome Tools. Additionally, PELOBiotech distributes products from partner suppliers including VitaCyte (highly-purified tissue dissociation enzymes), TissueClick (PhenoDrive biomimetic ECMs, Nanosperse), QRET Technologies (TR-FRET biosensors, Protein-Probe™ assays, QuickPick™ magnetic tools), and THT Biomaterials (human placenta-derived ECM proteins). The company also offers Animal Component-Free (ACF) solutions and supports applications in clinical GMP, industrial GMP, and research R&D.
Differentiator
Problem solved
Functional benefit
Brands
- Cellovations®: PELOBiotech's proprietary brand that incorporates all their experience and knowledge in cell culture. The brand offers cell culture media of the future, providing personalized access to advanced cell culture solutions.
Products and services
- Cellovations® Cell Culture Media
- Primary Cells (Human and Animal)
- Resyn® Recombinant Proteins and Tissue Dissociation Enzymes
- 3D Cell Culture Systems
- Cell Culture Tools and Reagents
- Assays
- Proteins and Antibodies
- Third-Party Distributed Life-Science Brands (Innoprot, Nexel, etc.)
Companies that use Pelo Biotech
Customer profileSegments3 records
Ideal customer profiles2 records
Pelo Biotech technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Pelo Biotech partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core and minor.
- VitaCytecoreVitaCyte is a US-based enzyme specialist and partner of PELOBiotech, offering the broadest line of highly-purified tissue dissociation enzymes including collagenases and proteases for basic research and cell therapy. Some products are available in GMP quality.
- abc biopplyminorSupplier of cell culture products distributed through PELOBiotech's portfolio.
- Akron BiotechminorSupplier of cell culture and biotech products distributed through PELOBiotech's portfolio.
- BioLife SolutionsminorSupplier of biopreservation tools and products distributed through PELOBiotech's portfolio.
- Cell ApplicationsminorSupplier of cell culture products distributed through PELOBiotech's portfolio.
- Cell BiologicsminorSupplier of cell biology products distributed through PELOBiotech's portfolio.
- CyagenminorSupplier of gene targeting and cell biology products distributed through PELOBiotech's portfolio.
- REPROCELLminorSupplier of stem cell and cell culture products distributed through PELOBiotech's portfolio.
Scale indicators2 records
Recent moves6 records
Expansion highlights6 records
Pelo Biotech competitors and assessment
Company assessmentDirect peers
- STEMCELL Technologies: Canada-based specialist in cell culture media, primary cells, and tools for stem cell and immunology research. Closely comparable on product mix, customer base (academic and biotech), and ACF/GMP positioning.
- Cyagen: Cell biology and gene targeting products supplier with strong iPS and stem cell offerings. Overlaps Pelo's iPS cell and stem cell categories and is also a Pelo distribution partner.
- Cell Applications: US-based supplier of primary cells and cell culture reagents. Directly overlaps Pelo's primary cell and media offering and is even listed as a Pelo supplier, making it a like-for-like comparison.
- REPROCELL: Japan-headquartered stem cell and iPS cell product company with a European presence. Comparable focus on iPS-derived cells, primary hepatocytes, and GMP reagents — also a Pelo distribution partner.
- PromoCell: German-based supplier of primary human cells, stem cells, and cell culture media. Directly comparable to Pelo on geography, primary cell portfolio, and specialty media positioning.
Broad incumbents
- Lonza Bioscience: Global leader in cell and gene therapy manufacturing, primary cells, and media. Overlaps Pelo's GMP-grade media, primary cells, and dissociation enzyme categories with a much larger manufacturing footprint.
- Corning Life Sciences: Major supplier of cell culture media, vessels, and 3D culture systems including Matrigel-equivalent ECM products. Directly competes in Pelo's media, ECM, and 3D culture categories.
- Bio-Techne (R&D Systems, Tocris, Novus): Large public life science tools company with deep catalogs in primary cells, media, proteins, antibodies, and assays. Comparable products across almost all of Pelo's core categories but at substantially larger scale.
- Thermo Fisher Scientific (Gibco): Industry-leading cell culture media (Gibco), primary cells, sera, and reagents. Directly overlaps Pelo's core media and reagent categories at a global incumbent scale.
Emerging players
- CellGenix: Germany-based supplier of GMP-grade raw materials and cell culture media for cell and gene therapy manufacturing. Highly comparable in geography and GMP positioning, though more focused on the clinical/industrial GMP niche.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks7 records
Key highlights6 records
Customer concentration
Pelo Biotech social profiles
Digital presencePelo Biotech financial estimates
Financial estimateRevenue estimate
Valuation estimate
Pelo Biotech leadership team
Management profileNumber of profiles
Profiles1 record
Pelo Biotech funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Pelo Biotech M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Pelo Biotech
What does Pelo Biotech do?
PELOBiotech GmbH develops, manufactures, and supplies specialty cell culture products for human primary cells, including a proprietary Cellovations® range of cell culture media (with Animal Component-Free and GMP-grade options), primary human and animal cells, stem cells, tissue dissociation enzymes, 3D cell culture systems, assays, proteins, and antibodies. The company serves as a one-stop shop for the cells–media–tools workflow and additionally distributes selected third-party life-science brands.
Is Pelo Biotech a public or private company?
Pelo Biotech is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Pelo Biotech founded?
Pelo Biotech was founded in 2012. It employs 11 to 50 people.
Where is Pelo Biotech based?
Pelo Biotech is headquartered in Martinsried, Germany, in the Europe region.
How does Pelo Biotech make money?
Two revenue lines are on record. Cell and Biological Products Sales are the primary driver. The others are supplier/Distribution Revenue.
Who are Pelo Biotech's main competitors?
Direct peers on record are STEMCELL Technologies, Cyagen, Cell Applications, REPROCELL and PromoCell. Broad incumbents are Lonza Bioscience, Corning Life Sciences, Bio-Techne (R&D Systems, Tocris, Novus) and Thermo Fisher Scientific (Gibco). CellGenix is listed as an emerging player.
Does Pelo Biotech have an API?
No public API is recorded for Pelo Biotech.
What industry is Pelo Biotech in?
Pelo Biotech's product category is Cell Culture Products and Life Science Reagents. Its primary akta.pro industry code is HLAGAIAG, Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers), with a secondary code of HLAAAJAI, Bioprocess Consumables & Reagents (resins, membranes, media components, buffers). Its NAICS code is 325414 and its SIC code is 2836.